Access brought to you by: LOCKSS

Renal Disease

A New Paradigm in Diabetic Nephropathy: Early Progressive Renal Decline
SYMPLICITY HTN-3 Trial: No Blood Pressure Reduction in Patients with Resistant Hypertension Treated with Renal Denervation
Results from the ROSE AHF Study
No Benefit to Renal Artery Stenting Seen in CORAL Trial
Renal Denervation and Renal Stenting are Beginning to Show Benefits in Hypertension and Other Conditions
Promising Advances in the Management of Adrenal Insufficiency
Catheter-Based Renal Artery Denervation – Sustained Blood Pressure Lowering with Reassuring Safety at 3 Years
Promises and Questions in Renal Denervation for Resistant Hypertension
Renal Denervation is Promising as a Treatment for Resistant Hypertension
Canagliflozin Reduces HbA1C in Patients with Stage 3 CKD, with the Change Greater in Patients with Higher eGFR

Pages